Gestation staae-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss

被引:44
|
作者
Boyson, JE
Nagarkatti, N
Nizam, L
Exley, MA
Strominger, JL [1 ]
机构
[1] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA
[2] Univ Vermont, Coll Med, Dept Surg, Div Transplantat Surg & Immunol, Burlington, VT 05405 USA
[3] Beth Israel Deaconess Med Ctr, Div Hematol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Med, Boston, MA 02215 USA
关键词
abortion; preterm birth; reproductive immunology;
D O I
10.1073/pnas.0511025103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Stimulation of CD1d-restricted semiinvariant natural killer T cells by using the Cd1d ligand alpha-galactosylceramide (alpha GalCer) induces pregnancy loss in mice through an ill-defined mechanism involving TNF, IFN-gamma, and perforin. In this article, we demonstrate that during early gestation, alpha GalCer efficiently induced pregnancy loss in C57BL/6J and BALB/cJ mice in a perforin-dependent manner. In contrast, during midgestation perforin was no longer required for pregnancy loss. Concomitant with the loss of a perforin requirement at midgestation was the emergence of strain-dependent variations in susceptibility to alpha GalCer-induced pregnancy loss. Whereas pregnant C57BL/6J mice remained susceptible to alpha GalCer at midgestation, pregnant BALB/cJ mice were resistant to its effects. Pregnancy loss during midgestation was correlated with dramatically higher serum cytokine levels, including TNF and IL-2, in the susceptible C57BL/6J strain compared with the resistant BALB/cJ strain. Thus, the stage of gestation defined two distinct mechanisms of pregnancy loss: a perforin-dependent mechanism operating at early gestation and a perforin-independent, cytokine-dominated mechanism operating after midgestation.
引用
收藏
页码:4580 / 4585
页数:6
相关论文
共 50 条
  • [1] Regulatory T cells decrease invariant natural killer T cell-mediated pregnancy loss in mice
    Li, L.
    Tu, J.
    Jiang, Y.
    Zhou, J.
    Schust, D. J.
    MUCOSAL IMMUNOLOGY, 2017, 10 (03) : 613 - 623
  • [2] Mechanisms of natural killer cell-mediated cellular cytotoxicity
    Prager, Isabel
    Watzl, Carsten
    JOURNAL OF LEUKOCYTE BIOLOGY, 2019, 105 (06) : 1319 - 1329
  • [3] Mixed Signals: Co-Stimulation in invariant Natural Killer T Cell-Mediated Cancer immunotherapy
    Shissler, Susannah C.
    Lee, Michael S.
    Webb, Tonya J.
    FRONTIERS IN IMMUNOLOGY, 2017, 8
  • [4] Peripheral Dopamine Controlled by Gut Microbes Inhibits Invariant Natural Killer T Cell-Mediated Hepatitis
    Xue, Rufeng
    Zhang, Huimin
    Pan, Jun
    Du, Zhiwei
    Zhou, Wenjie
    Zhang, Zhi
    Tian, Zhigang
    Zhou, Rongbin
    Bai, Li
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [5] Mechanisms of Natural Killer Cell-mediated Tumor Cell Cytolysis at a Single Cell Level
    王小宁
    李文简
    Journal of Medical Colleges of PLA, 1987, (02) : 107 - 117
  • [6] Mechanisms of resistance to natural killer cell-mediated cytotoxicity in acute lymphoblastic leukemia
    Romanski, A
    Bug, G
    Becker, S
    Kampfmann, M
    Seifried, E
    Hoelzer, D
    Ottmann, OG
    Tonn, T
    EXPERIMENTAL HEMATOLOGY, 2005, 33 (03) : 344 - 352
  • [7] Role of invariant natural killer T cells in lipopolysaccharide-induced pregnancy loss
    Li, Liping
    Shi, Lijuan
    Yang, Xinying
    Ren, Lihua
    Yang, Jing
    Lin, Yi
    CELLULAR IMMUNOLOGY, 2013, 286 (1-2) : 1 - 10
  • [8] Natural Killer Cell-Mediated Immunotherapy for Leukemia
    Allison, Michaela
    Mathews, Joel
    Gilliland, Taylor
    Mathew, Stephen O.
    CANCERS, 2022, 14 (03)
  • [9] Natural killer cell-mediated immunotherapy of hepatoblastoma
    Vatlach, M.
    Pfeiffer, M.
    Seitz, G.
    Ruck, P.
    Heitmann, H.
    Treuner, C.
    Mueller, C. A.
    Steinle, A.
    Lang, P.
    Handgretinger, R.
    Fuchs, J.
    Warmann, S. W.
    KLINISCHE PADIATRIE, 2008, 220 (03): : 210 - 210
  • [10] Invariant natural killer T cell-mediated cytokine secretion is a potential biomarker to monitor the efficacy of treatment for Fabry disease
    Gwalani, Lavesh
    Chi, Joshua
    Wu, Rui
    Dalrymple, Margaret
    Palliser, Deborah
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S46 - S46